Health
Synthetic Mini-Antibody Binds to and Neutralizes SARS-CoV-2 – Technology Networks
Extremely small antibodies, known as nanobodies, have been shown to neutralize SARS-CoV-2. But they’re extracted from llamas and camels, which is problematic for…
Llamas, camels and COVID-19
For SARS-CoV-2 to infect humans, the viral Spike (S) protein must interact with and bind to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of human cells. The S protein achieves this via the receptor binding domains (RBDs), and thus blocking the RBD using antibodies is just one therapeutic avenue that is being explored for the treatment of SARS-CoV-2. Back in May, Technology Networks covered the work of scientists exploring the potential utility of…
-
General13 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News13 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business20 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!